Form 4: CVS Health EVP and CFO Thomas F. Cowhey Reports Transactions
SEC Form 4 Filing
Thomas F. Cowhey, EVP and CFO of CVS Health, reports acquisition and disposal of CVS stock and stock options.
Summary
- On April 1, 2025, Thomas F. Cowhey, EVP and CFO of CVS Health, reported transactions involving CVS Health Corp [CVS] stock.
- Cowhey surrendered 3,203 shares of common stock to cover withholding taxes due upon the vesting and settlement of restricted stock units at a price of $67.98.
- Cowhey acquired 16,181 shares of restricted common stock at a price of $67.98.
- Cowhey was also awarded 68,621 stock options with an exercise price of $67.98.
- The restricted stock units vest in four equal installments, starting April 1, 2026.
- The stock options become exercisable in four equal annual installments, commencing on April 1, 2026.
Sentiment
Score: 6
Explanation: The document reflects standard executive compensation practices. It's neutral in sentiment, indicating routine transactions rather than a significant shift in company outlook.
Positives
- The granting of restricted stock units and stock options to the CFO suggests a long-term incentive and alignment with the company's success.
Future Outlook
The restricted stock units vest and the stock options become exercisable in future years, aligning the executive's interests with the long-term performance of the company.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors to gauge executive sentiment and potential future performance.
Comparison to Industry Standards
- Stock option and restricted stock unit grants are common compensation practices for executives in publicly traded companies like CVS Health.
- Companies like UnitedHealth Group (UNH) and Cigna (CI) also utilize similar equity-based compensation plans to incentivize their executives.
- The vesting schedules and exercise prices are generally aligned with industry norms to retain and motivate key personnel.
Stakeholder Impact
- Shareholders can monitor insider transactions to gain insights into management's perspective on the company's value.
- Employees may be indirectly affected by executive compensation structures, as they can influence overall company performance and culture.
Key Dates
| Date | Description |
|---|---|
| 04/01/2025 | Date of transactions: surrender of shares for taxes, acquisition of restricted stock units, and grant of stock options. |
| 04/01/2026 | First vesting date for restricted stock units in four equal installments. |
| 04/01/2026 | First date stock options become exercisable in four equal annual installments. |
| 04/02/2035 | Expiration date of the stock options. |
| 04/03/2025 | Date of signature on the Form 4 filing. |
Keywords
CVS Health, Thomas F. Cowhey, Stock Options, Restricted Stock Units, Form 4, Insider Trading, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.